These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29253405)

  • 1. Beyond availability and affordability: how access to medicines affects non-communicable disease outcomes.
    Wirtz VJ; Moucheraud C
    Lancet Public Health; 2017 Sep; 2(9):e390-e391. PubMed ID: 29253405
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to essential medicines to treat chronic respiratory disease in low-income countries.
    Bissell K; Perrin C; Beran D
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
    Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
    PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping with access barriers to non-communicable disease medicines: qualitative patient interviews in eight counties in Kenya.
    Ng G; Raskin E; Wirtz VJ; Banks KP; Laing RO; Kiragu ZW; Rockers PC; Onyango MA
    BMC Health Serv Res; 2021 May; 21(1):417. PubMed ID: 33941177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access.
    Sado E; Sufa A
    BMC Pediatr; 2016 Mar; 16():40. PubMed ID: 26979737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncommunicable diseases, access to essential medicines and universal health coverage.
    Beran D; Pedersen HB; Robertson J
    Glob Health Action; 2019; 12(1):1670014. PubMed ID: 31573421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Price Variation and Availability of Free Medicine for Non-communicable Diseases.
    Devkota A; Paudel A; Koirala B; Baral D; Gautam S; Sharma SK
    J Nepal Health Res Counc; 2018 Jul; 16(2):118-123. PubMed ID: 29983422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming Obstacles To Enable Access To Medicines For Noncommunicable Diseases In Poor Countries.
    Kishore SP; Kolappa K; Jarvis JD; Park PH; Belt R; Balasubramaniam T; Kiddell-Monroe R
    Health Aff (Millwood); 2015 Sep; 34(9):1569-77. PubMed ID: 26355060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Heart Failure Medicines in Low- and Middle-Income Countries: An Analysis of Essential Medicines Lists, Availability, Price, and Affordability.
    Agarwal A; Husain MJ; Datta B; Kishore SP; Huffman MD
    Circ Heart Fail; 2022 Apr; 15(4):e008971. PubMed ID: 35249355
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving access to medicines for non-communicable diseases, including mental health conditions.
    Minghui R; Simão M; Mikkelsen B; Kestel D; Wu D
    Lancet; 2023 Jun; 401(10393):2023-2025. PubMed ID: 36842440
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving global access to medicines for non-communicable diseases.
    Beran D; Perrin C; Billo N; Yudkin JS
    Lancet Glob Health; 2014 Oct; 2(10):e561-2. PubMed ID: 25304626
    [No Abstract]   [Full Text] [Related]  

  • 12. Service Readiness For Noncommunicable Diseases Was Low In Five Countries In 2013-15.
    Moucheraud C
    Health Aff (Millwood); 2018 Aug; 37(8):1321-1330. PubMed ID: 30080459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Household access to non-communicable disease medicines during universal health care roll-out in Kenya: A time series analysis.
    Kiragu ZW; Rockers PC; Onyango MA; Mungai J; Mboya J; Laing R; Wirtz VJ
    PLoS One; 2022; 17(4):e0266715. PubMed ID: 35443014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaps in access to essential medicines and health products for noncommunicable diseases and mental health conditions.
    Minghui R; Simao M; Mikkelsen B; Kestel D; Ball A; Szilagyi Z
    Bull World Health Organ; 2020 Sep; 98(9):582-582A. PubMed ID: 33012854
    [No Abstract]   [Full Text] [Related]  

  • 15. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 16. The crisis in access to essential medicines in India: key issues which call for action.
    Bhargava A; Kalantri SP
    Indian J Med Ethics; 2013; 10(2):86-95. PubMed ID: 23697486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are essential medicines in Malaysia accessible, affordable and available?
    Saleh K; Ibrahim MI
    Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forecasting the quantity and cost of medicines to treat non-communicable diseases in low- and middle-income countries: Applying knowledge on medicine use from developed countries.
    Khanal S; Veerman L; Nissen L; Hollingworth S
    Res Social Adm Pharm; 2017; 13(1):257-258. PubMed ID: 27591096
    [No Abstract]   [Full Text] [Related]  

  • 19. Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study.
    Perumal-Pillay VA; Suleman F
    BMC Health Serv Res; 2017 Jun; 17(1):417. PubMed ID: 28629443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability of essential medicines in Ethiopia: an efficiency-equity trade-off?
    Carasso BS; Lagarde M; Tesfaye A; Palmer N
    Trop Med Int Health; 2009 Nov; 14(11):1394-400. PubMed ID: 19754520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.